Company · CIK 0001382574 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Scienture Holdings, Inc. · SCNX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| May 15, 2025 AForm 5 → | Aug 31, 2026, 5:09 pm EDT | Eric Michael SherbChief Financial Officer | 50,000 | — | — | 50,000 | — | |
| Nov 15, 2017 SForm 4 → | Feb 12, 2018, 5:03 pm EST | Surendra K AjjarapuCEO, Director, 10% Owner | 250,000 | $112,500.00 | $28,125,000,000 | 13,743,750 | −1.79% | plan? late |
| Dec 30, 2016 GForm 4 → | Apr 24, 2017, 7:02 pm EDT | Surendra K AjjarapuCEO, Director, 10% Owner | 156,250 | $101,563.00 | $15,869,218,750 | 13,993,750 | — | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 26, 2018 AForm 4 → | Apr 30, 6:11 pm EDT | Howard A. DossCFO | 37,500 | — | — | 304,500 | — | |
| Apr 26, 2018 AForm 4 → | Apr 30, 5:59 pm EDT | Donald G. FellDirector | 50,000 | — | — | 184,423 | — | |
| Apr 26, 2018 AForm 4 → | Apr 30, 5:43 pm EDT | Michael L PetersonDirector | 50,000 | — | — | 114,423 | — | |
| Apr 7, 2017 AForm 5 → | Feb 14, 2018, 6:19 pm EST | Michael L PetersonDirector | 176,923 | — | — | 0 | — | |
| Apr 1, 2016 AForm 5 → | Feb 14, 2018, 6:19 pm EST | Howard A. DossCFO | 15,000 | — | — | 15,000 | — | |
| Apr 1, 2016 AForm 5 → | Feb 14, 2018, 6:18 pm EST | Donald G. FellDirector | 101,923 | — | — | 0 | — |